Teva Pharmaceutical Industries Ltd ADR TEV
News
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 1.17B
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 15.35
- Price/Sales
- 2.47
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 32,842
- Website
- https://www.tevapharm.com
Valuation
|
Metric
|
TEV
|
|---|---|
Price/Earnings (Normalized) | 15.35 |
Price/Book Value | 5.41 |
Price/Sales | 2.47 |
Price/Cash Flow | 14.21 |
Price/Earnings
TEV
Financial Strength
|
Metric
|
TEV
|
|---|---|
Quick Ratio | 0.46 |
Current Ratio | 0.88 |
Interest Coverage | 1.79 |
Quick Ratio
TEV
Profitability
|
Metric
|
TEV
|
|---|---|
Return on Assets (Normalized) | 6.68% |
Return on Equity (Normalized) | 35.32% |
Return on Invested Capital (Normalized) | 14.43% |
Return on Assets
TEV
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|sPbZwS? | LOCK|G$<B | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|N%pcfxy | LOCK|Z@#p | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|btppcSw | LOCK|#G% | $45B | |||
| Zoetis Inc Class A
ZTS
| LOCK|l$Wy#y#W | LOCK|Xf& | $33B | |||
| Viatris Inc
VTRS
| LOCK|btng!@ | LOCK|!&v | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|#CY | LOCK|nZR | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|>B&#^> | LOCK|Wpj | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|Q>q!RLS | LOCK|^@ | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|$%>hJp | LOCK|yG$<@ | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|HJk<@?Q | LOCK|!> | $2B |
United States